Manchester Capital Management’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.6K | Buy |
323
+76
| +31% | +$5.56K | ﹤0.01% | 675 |
|
|
2026
Q1 | $18.9K | Buy |
247
+210
| +568% | +$15.1K | ﹤0.01% | 688 |
|
|
2025
Q4 | $2.36K | Sell |
37
-54
| -59% | -$3.33K | ﹤0.01% | 993 |
|
|
2025
Q3 | $5.74K | Buy |
91
+19
| +26% | +$1.33K | ﹤0.01% | 935 |
|
|
2025
Q2 | $5.38K | Sell |
72
-51
| -41% | -$4.01K | ﹤0.01% | 896 |
|
|
2025
Q1 | $10.8K | Sell |
123
-71
| -37% | -$6.7K | ﹤0.01% | 802 |
|
|
2024
Q4 | $17.7K | Hold |
194
| – | – | ﹤0.01% | 723 |
|
|
2024
Q3 | $21.7K | Sell |
194
-1
| -0.5% | -$100 | ﹤0.01% | 675 |
|
|
2024
Q2 | $19.1K | Buy |
195
+12
| +7% | +$1.19K | ﹤0.01% | 664 |
|
|
2024
Q1 | $18.3K | Buy |
183
+53
| +41% | +$4.66K | ﹤0.01% | 561 |
|
|
2023
Q4 | $11.7K | Buy |
130
+7
| +6% | +$558 | ﹤0.01% | 592 |
|
|
2023
Q3 | $9.44K | Buy |
123
+2
| +2% | +$166 | ﹤0.01% | 590 |
|
|
2023
Q2 | $10.1K | Sell |
121
-4
| -3% | -$325 | ﹤0.01% | 545 |
|
|
2023
Q1 | $10.5K | Buy |
125
+20
| +19% | +$1.72K | ﹤0.01% | 534 |
|
|
2022
Q4 | $8.55K | Sell |
105
-865
| -89% | -$69.7K | ﹤0.01% | 482 |
|
|
2022
Q3 | $69K | Sell |
970
-52
| -5% | -$4.67K | 0.01% | 336 |
|
|
2022
Q2 | $92K | Buy |
1,022
+984
| +2,589% | +$102K | 0.02% | 312 |
|
|
2022
Q1 | $4K | Hold |
38
| – | – | ﹤0.01% | 676 |
|
|
2021
Q4 | $5K | Hold |
38
| – | – | ﹤0.01% | 662 |
|
|
2021
Q3 | $4K | Hold |
38
| – | – | ﹤0.01% | 724 |
|
|
2021
Q2 | $4K | Hold |
38
| – | – | ﹤0.01% | 592 |
|
|
2021
Q1 | $4K | Sell |
38
-4
| -10% | -$434 | ﹤0.01% | 545 |
|
|
2020
Q4 | $4K | Buy |
+42
| New | +$3.9K | ﹤0.01% | 544 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | – | – | 547 |
|
|
2018
Q1 | $0 | Buy |
+2
| New | +$202 | ﹤0.01% | 578 |
|
|
2015
Q1 | – | Sell |
-176
| Closed | -$13K | – | 634 |
|
|
2014
Q4 | $13K | Hold |
176
| – | – | ﹤0.01% | 935 |
|
|
2014
Q3 | $14K | Hold |
176
| – | – | ﹤0.01% | 918 |
|
|
2014
Q2 | $15K | Hold |
176
| – | – | ﹤0.01% | 895 |
|
|
2014
Q1 | $15K | Sell |
176
-21
| -11% | -$1.72K | ﹤0.01% | 800 |
|
|
2013
Q4 | $16K | Hold |
197
| – | – | ﹤0.01% | 745 |
|
|
2013
Q3 | $15K | Sell |
197
-77
| -28% | -$5.93K | ﹤0.01% | 775 |
|
|
2013
Q2 | $19K | Buy |
+274
| New | +$19.1K | ﹤0.01% | 755 |
|
Other funds holding EMN
Manchester Capital Management's EMN Position: Q2 2026 in Review
Manchester Capital Management increased its Eastman Chemical (EMN) stake by 31% in Q2 2026, buying an estimated $5.56K and bringing the position to 323 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #675.
Manchester Capital Management first reported a position in EMN in Q2 2013 and has held it in 31 quarters since. The position peaked at $92K in Q2 2022. 646 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Manchester Capital Management held 323 shares of Eastman Chemical worth $21.6K as of Q2 2026.
- Manchester Capital Management bought 76 Eastman Chemical shares in Q2 2026, an estimated $5.56K.
- Eastman Chemical made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #675 holding.
- Manchester Capital Management first reported a position in Eastman Chemical in Q2 2013 and has held it in 31 quarters since.
- Manchester Capital Management's Eastman Chemical position peaked at $92K in Q2 2022.
- 646 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.